Clinical Trial Update: Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reporting on the efficacy and safety of TAK-385 for uterine fibroids, with the study status shown as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• TAK-385

Snippet

Sponsor: Takeda | Conditions: Uterine Fibroids | Phase 2 | Status: COMPLETED